A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy

Journal:
The New England Journal of Medicine
Published:
DOI:
10.1056/nejmoa2510198
Affiliations:
21
Authors:
21
Institutions Authors Share
Vera Therapeutics, Inc., United States of America (USA)
3.000000
0.14
Peking University First Hospital, PKUHSC, China
1.000000
0.05
AZ Delta, Belgium
1.000000
0.05
Stanford University, United States of America (USA)
1.000000
0.05
Institute of Postgraduate Medical Education and Research, India
1.000000
0.05
The University of British Columbia (UBC), Canada
1.000000
0.05
British Hospital, Argentina
1.000000
0.05
The George Institute - India (TGI India), India
1.000000
0.05
University of Leicester, United Kingdom (UK)
1.000000
0.05
University Hospital Aachen (UKA), RWTH Aachen, Germany
1.000000
0.05
Charles University (CU), Czech Republic
1.000000
0.05
Juntendo University Urayasu Hospital, Japan
1.000000
0.05
Yonsei University, South Korea
1.000000
0.05
Mount Elizabeth Novena Hospital, Singapore
1.000000
0.05
The University of Alabama at Birmingham (UAB), United States of America (USA)
1.000000
0.05
Kocaeli University, Turkey
1.000000
0.05
University of Pennsylvania (Penn), United States of America (USA)
1.000000
0.05
Arbor Research Collaborative for Health, United States of America (USA)
0.500000
0.02
The University of Sydney (USYD), Australia
0.500000
0.02
Pontifical Catholic University of Paraná (PUCPR), Brazil
0.500000
0.02
Westmead Hospital (WSLHD), Australia
0.500000
0.02